Saline (0.9%, sterile, for infusion)
Sponsors
Stealth BioTherapeutics Inc., Qingyuan Zhan, Ricardo Mora, HTIC, Inc
Conditions
ARDS (Acute Respiratory Distress Syndrome)Adenovirus Infections, HumanExerciseHealthy VolunteersHyperlactatemiaInfluenzaLipolysisMetabolic Syndrome (MetS)
Phase 1
Study to Assess the Pharmacodynamic Effects of Unfractionated Heparin (UFH) in Healthy Volunteers With and Without Bendavia
CompletedNCT01513200
Start: 2012-01-31End: 2012-02-29Updated: 2012-04-19
Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT31-1 for Treating ARDS
Not yet recruitingNCT07449572
Start: 2026-03-01End: 2026-11-01Target: 24Updated: 2026-03-04
Phase 3
Adaptive RCT of Corticosteroids for Severe Adenovirus Pneumonia in Adults
Not yet recruitingNCT07152600
Start: 2026-02-01End: 2027-12-31Target: 262Updated: 2026-01-21
Corticosteroids for PJP in Non-HIV Immunocompromised Adults
Not yet recruitingNCT07152613
Start: 2025-09-08End: 2027-12-31Target: 240Updated: 2025-09-09
Adaptive RCT of Corticosteroids for Severe Influenza Pneumonia in Adults
Not yet recruitingNCT07351500
Start: 2026-01-15End: 2028-11-30Target: 496Updated: 2026-01-20
Adaptive RCT of Corticosteroids for Severe Chlamydia Psittaci Pneumonia in Adults
Not yet recruitingNCT07352865
Start: 2026-01-15End: 2028-11-30Target: 100Updated: 2026-01-20